
Antineoplastic drugs prescription during visits by adult cancer patients with comorbidities: findings from the 2010–2016 National Ambulatory Medical Care Survey
Author(s) -
Loredana Santo,
Brian Ward,
Pinyao Rui,
Jill J Ashman
Publication year - 2020
Publication title -
ccc. cancer causes and control/ccc, cancer causes and control
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.073
H-Index - 134
eISSN - 1573-7225
pISSN - 0957-5243
DOI - 10.1007/s10552-020-01281-5
Subject(s) - medicine , comorbidity , ambulatory , breast cancer , cancer , colorectal cancer , medical prescription , prostate cancer , diabetes mellitus , copd , lung cancer , physical therapy , pharmacology , endocrinology
Cancer treatment may be affected by comorbidities; however, studies are limited. The purpose of this study is to examine the frequency of comorbidities at visits by patients with breast, prostate, colorectal, and lung cancer and to estimate frequency of a prescription for antineoplastic drugs being included in the treatment received at visits by patients with cancer and concomitant comorbidities.